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Five-year outcome study of deep vein thrombosis
in the lower limbs
Akram M. Asbeutah, MS,a Andrea Z. Riha, MBBS,b James D. Cameron, MD,a and Barry P. McGrath,
MD,a Melbourne and Brisbane, Australia
Objective: Venous disease was evaluated in relation to post-thrombotic syndrome 5 years after deep venous thrombosis
(DVT) in patients treated with a regimen of low-molecular-weight heparin (LMWH) and warfarin in a Hospital-in-the-
Home program.
Methods: The presence of flow, reflux and compressibility in 51 patients (102 limbs, 54 with DVT and 48 without DVT)
was assessed by duplex ultrasound scanning. Blood tests were carried out for prothrombotic screening. Venous disease
was related to pathologic severity of post-thrombotic syndrome, characterized by the CEAP (clinical, etiologic, anatomic,
pathophysiologic) classification on a scale of 0 to 6.
Results: In the 102 limbs studied, 30 patients (59%) had an underlying thrombophilic disorder. The most common cause
of DVT was postoperation and prolonged immobilization not related to postoperation. The most common thrombo-
philic abnormalities were anticardiolipin antibody and a deficiency of protein C or S, or both. Twenty-six limbs (48%) had
proximal involvement (proximal and proximal plus distal DVT); resolution (recanalization or normal vein) in these limbs
was seen in 85% at 6 months and 96% at 5 years. After 5 years, 25 of these proximal DVT limbs (96%) developed reflux
and there were 4 limbs in CEAP class 0, 8 in classes 1 to 3, and 14 in classes 4 to 6. All of the 28 limbs (52%) with distal
DVT showed DVT resolution by 6 months. After 5 years, 10 limbs (36%) developed reflux, and 13 limbs were in class 0,
12 in classes 1 to 3, and 3 limbs in classes 4 to 6. No DVT was detected in the 48 contralateral limbs, but reflux was
detected in 25 limbs (52%), predominately in the superficial veins (16 limbs, 64%).
Conclusions: The resolution of thrombus was more rapid and complete in patients with distal DVT than in those with
proximal DVT. Patients with proximal DVT developed a more severe form of post-thrombotic syndrome that was likely
related to the development of deep venous reflux. An important finding of this study was an unexpectedly high incidence
of venous reflux in the apparently unaffected limb. Although these non-DVT limbs were not investigated at presentation,
our data is consistent with the hypothesis that DVT may result in a more systemic disorder of venous function. (J Vasc
Surg 2004;40:1184-9.)The likelihood that chronic venous insufficiency (CVI)
will develop after deep vein thrombosis (DVT) increases
with the passage of time. DVT may cause persistent venous
abnormalities, resulting in post-thrombotic syndrome. Af-
ter DVT, 20% to 30% of patients will progress to skin
pigmentation changes and 3% to 5% to ulceration.1,2 Pa-
tients with a history of DVT have a 26-fold increased risk
for CVI compared with patients without a history of DVT.3
The potential mechanisms whereby a past history of DVT
may result in CVI include persistent venous outflow ob-
struction, venous valvular incompetence, or calf muscle
pump dysfunction.4-7 It is unclear how much these differ-
ent mechanisms are independent.
The rate of resolution of thrombosis in patients with
DVT varies, depending on the site and degree of occlusion
of the initial thrombus, the duration and intensity of ongo-
ing anticoagulant treatment, and plasma fibrinolytic activ-
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1184ity.4,8 Rapid recanalization after DVT is associated with a
higher incidence of valve competency.9 The chronic sequelae
of DVT are more often ascribed to reflux than to obstruc-
tion.5,10-12 Reflux, however, is not confined only to those
veins that were occluded at the time of presentation, and up to
one third of venous segments demonstrating reflux are not
involved with thrombosis at the time of the initial DVT.13
A number of studies have identified deep venous reflux
as a significant contributor to symptom progression in
CVI.14,15 Neglen and Raju16 showed an incidence of deep
reflux in 29%, 82%, and 94% of limbs with no signs, mild-
to-moderate signs, and severe signs of venous disease,
respectively. Others have also shown increasing deep ve-
nous reflux with the progression of clinical symptoms of
CVI.17-19 The presence of CVI in the popliteal vein is
considered to be important in the pathophysiology of post-
thrombotic syndrome.20-22
This study progressively evaluated venous hemody-
namics in relation to the severity of the post-thrombotic
syndrome for up to 5 years after the initial venous throm-
bosis.8 Persistence of symptoms and signs of CVI were
recorded. A novel aspect of this study was an investigation
of the prevalence of CVI and reflux in the nonaffected legs.
MATERIALS AND METHODS
Subjects. The study group consisted of 51 patients
who had a DVT confirmed by duplex ultrasound scanning
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who were treated with low-molecular-weight heparin
(LMWH) in a Hospital-in-Home program, as previously
reported.8 The study was approved by the Human Re-
search and Ethic Committee of Southern Health, Mel-
bourne, Australia, and informed consent was obtained
from all the participants.
All patients were treated with the LMWH, dalteparin
(Fragmin), administered subcutaneously for 2 to 5 days
during the acute phase, and with warfarin commencing day
2 and continuing for at least 3 months.8 All patients had
been instructed to wear graduated compression stockings
for a minimum of 4 weeks for those with proximal DVTs
and 2 weeks for those with distal DVTs. Compliance was
not assessed. Duplex venous ultrasound imaging studies
were performed in all study subjects at 1 week, 1, 3, 6, and
12 months, and at 5 years after the documented DVT.
Clinical assessment. All patients underwent a clinical
review by telephone questionnaire at 12 months and a
physical examination by a vascular physician at 5 years.
Patients were classified according to the seven-point CEAP
scale (class 0 to 6) of the update of the Ad Hoc Committee
on Reporting Standards in Venous Disease.23 For simplic-
ity, the tables and figures are presented categorized as
patients with no signs of venous disease (class 0); those with
mild signs of venous disease (classes 1 to 3); and those with
skin changes and severe signs of venous disease (classes 4 to
6). At 12 months of follow-up, study subjects were classi-
fied clinically according to the following scoring system: no
venous disease (equivalent to CEAP class 0); pain and
swelling (mild or moderate, CEAP classes 1 to 3); and color
changes or ulceration, or both (CEAP classes 4 to 6).
In all study subjects at 5-year follow-up, venous blood
(25 mL) was withdrawn and sent for hematologic and
biochemistry analysis. This included platelet count, hemo-
globulin concentration, and white blood cell count, and
prothrombotic screening comprising protein C, protein S,
antithrombin III, activated protein resistance C, factor
VIII, prothrombin 20210A, lupus anticoagulant, anticar-
diolipin antibody, homocysteine, and factor V Leiden.
Duplex ultrasound scanning. B-mode, color flow
imaging, and Doppler spectral analysis were performed in
both legs by using an ATL 5000 HDI scanner with a linear
7-4 MHz transducer on the low-flow setting. All patients
were gowned and undergarments removed as these may
alter the findings, particularly if there is pelvic venous
incompetence involved. The room temperature was stan-
darized at 22° C. The subject was rested (sitting or lying)
for at least 20 minutes prior to the examination to exclude
exercise-associated hyperemia that can cause continuous
venous outflow.
The veins examined were the common femoral, super-
ficial femoral (proximal and distal), profunda femoris, pop-
liteal (proximal and distal), posterior tibial (proximal two
thirds and distal one third), peroneal (proximal two thirds
and distal one third), long saphenous (proximal, distal, and
calf), and short saphenous (calf). Eighteen segments were
examined in each leg.The examination commenced with the study of the
common femoral, profunda femoris, superficial femoral,
and long saphenous veins with the patient facing the exam-
iner. The popliteal and short saphenous veins were then
examined with the study subject facing away from the
examiner and slightly flexing the knee. All veins were ex-
amined with patients standing, holding onto a frame with
the weight mainly on the opposite leg, and keeping the leg
under examination in a relaxed position with the knee
slightly flexed. Lastly, for the tibial veins and long saphe-
nous vein at the calf, the subject sat on the couch while the
foot rested on a chair.
Proximal DVT was defined as thrombus involving the
popliteal or more proximal veins (or both). Distal DVTwas
defined as thrombus involving any or all of the tibial veins
but without involvement of the popliteal or more proximal
veins.
The compression method was used to assess thrombus
resolution.24 The vein segment being examination was
classified as “normal” when it was compressible with gentle
transducer pressure and showed normal flow with color
flow imaging; “recanalized” if the vein wall could be ap-
proximated, even if not completely, and flow was evident
with color flow imaging; and “occluded” if the segment
could not be compressed at all with high echoes in the
lumen, irregular thick wall, and with no flow on color flow
imaging. The DVT was considered “resolved” if the vein
segment was recanalized or normal in appearance, or “non-
resolved” if the vein segment showed no evidence of recan-
alization or remained occluded, or both.
Reflux was evaluated at the same time in a longitudinal
plane. The transducer was held still, color flow was
switched on, and distal manual compression was performed
prior to the use of an automatic cuff technique. Reflux was
indicated by a vein lumen that filled with one color on
compression and with a different color on release that
persisted for a prolonged period. Then, the pulsed Doppler
scanner was switched on, and the Doppler sample volume
was placed in the mid vessel at less than 60 degrees to the
long axis of the vessel, with a central sample range of
between one half and one third of the vessel width.
Venous flow augmentation was accomplished by plac-
ing a 10-cm pneumatic cuff connected to a Hokanson E20
automatic inflator (Issaquah, Wash) immediately distal to
the venous segment under examination. A pressure of 100
mm Hg was used. An automatic cuff inflator was used to
provide inflation within 3 seconds but, most importantly,
deflation within 0.5 seconds. To ensure rapid inflation/
deflation times, a large inflation/deflation tube size was
connected to the 10-cm cuff size. Reflux in the deep or
superficial venous system was detected when the duration
of reflux was more than 0.5 seconds.25 The duration of
reflux was measured by the time scale of the Doppler trace.
When incompetent perforator veins were identified in
the calf or thigh, the direction of flow was assessed after
manual compression distal to the perforator with the color
flow mode on. They were documented in size and distance
from the medial malleolus.
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into a database (Microsoft Access) that detailed the pa-
tient’s characteristics, sites and locations of initial DVT,
thrombus resolution at different time intervals, reflux de-
velopment, blood findings, and clinical assessment of each
limb. The data was analyzed with the Statistical Package for
Social Sciences (SPSS) software (Chicago, Ill).
RESULTS
The characteristics of the 51 patients (21 men and 30
women) are shown in Table I. At the time of the follow-up
study, their mean age was 51.7 years (range, 23 to 82
years). Mean  SD for body mass index was 28.1  5.5
kg/m2. Fifty-four of the 102 lower limbs had previous
history of DVT, and the remaining 48 limbs were without
previous DVT history. There were 26 proximal DVTs (1
extended to the iliac veins) and 28 distal DVTs.
Risk factors. Predisposing risk factors for DVT in
these patients are shown in Table II. Study participants
were divided into two groups according to whether there
was an underlying thrombophilic disorder. The most com-
mon thrombophilic abnormalities were the presence of
anticardiolipin antibody (16 subjects) and deficiency of
Table I. Characteristics of the study subjects at follow-
up examination
Characteristic
Age (years) (mean  SD) 55.3  16.2
Male:female 21:30
BMI (kg/m2) (mean  SD) 28.1  5.5
Period of follow up (months) (mean  SD) 60  5
Site of index DVT
Right lower limbs (%) 19 (35%)
Left lower limbs (%) 32 (59%)
Both limbs (%) 3 (6%)
Location of thrombi at initial scans
Proximal (%) 4 (7%)
Proximal and distal (%) 22 (41%)
Distal (%) 28 (52%)
BMI, Body mass index; DVT, deep vein thrombosis.
Table II. Clinical risk factors for deep venous
thrombosis
Thrombophilia
(n)
No thrombophilia
(n)
Postoperative 12 9
Prolonged immobility (not
related to operation)
7 9
Hormonal therapy in
women
4 4
First-degree family history of
DVT
5 1
Past history of DVT 2 0
Malignancy 3 0
Idiopathic 3 2
DVT, Deep vein thrombosis.protein C (8 subjects) and S (4 subjects). The remainingthrombophilic disorders were antithrombin III (7 sub-
jects), activated protein C resistance (6 subjects), factor V
Leiden (4 subjects), and hyperhomocysteinemia (3 sub-
jects).
Thrombus resolution and clinical classification.
The results of follow-up of thrombus resolution are sum-
marized in Fig 1. In 26 limbs with proximal involvement,
resolution at 1 week, 6 months, and 5 years was seen in
34%, 85%, and 96%, respectively. In the 28 limbs with distal
DVT, the resolution at the same time periods was 67%,
100%, and 100%, respectively. Five patients (9%) had a
DVT recurrence within the first 2 years. No subsequent
recurrences were detected.
A comparison of clinical classes at 12 months and 5
years after proximal and distal DVTs is shown in Table III.
At 5 years follow-up, study subjects with any proximal
DVT, which includes distal DVT with proximal extension,
had 4 limbs (15%) in class 0, 8 limbs (31%) in classes 1 to 3,
and 14 limbs (54%) in classes 4 to 6. Study subjects with
distal DVT, at 5 years follow-up, had 13 limbs (46%) in
class 0, 12 limbs (43%) in classes 1 to 3, and only 3 limbs
(11%) in classes 4 to 6. The persistence of more severe
symptoms of CVI at 5 years was greater in those who had a
proximal DVT (14/26) than in those with a distal DVT
(3/28) (2  9.7, P  .01).
Reflux development. Reflux development in the
Fig 1. Evaluation of changes in lower limb deep vein thrombosis
(DVT) status, as assessed by duplex ultrasound scanning at 65
months and compared with data at 7 days and 6 months for
proximal and distal-plus-proximal and distal thrombosis and
scored as resolved or nonresolved.DVT and non-DVT limbs is summarized in Table IV. Of
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these had incompetent perforators. The reflux was in both
the proximal and distal part of the limbs, with most show-
ing reflux in the deep venous system.
Reflux was observed after 5 years in all but one of the 26
proximal DVT limbs compared with 10 of the 28 distal
DVT limbs. Of the 35 DVT limbs that showed reflux, 17
developed progressive CVI with evidence of deep venous
reflux in 15 and superficial venous reflux in 14. The most
common pattern (12/17) was the combination of deep
plus superficial plus perforator venous incompetence. In
the 48 contralateral limbs without any history of DVT, 25
limbs (52%) exhibited reflux and most of this reflux was in
the superficial venous system (16 limbs, 64%).
Fig 2 examines the mean CEAP clinical classes in rela-
tion to the site of venous reflux in post-DVT and non-DVT
limbs. Symptoms were more severe in those limbs with
superficial venous reflux (including deep plus superficial
reflux) compared with those limbs with deep venous reflux
alone. Incompetent deep perforators were detected in 21
(62%) of the 35 limbs with superficial venous reflux com-
pared with 9 (43%) of the 21 limbs with deep venous reflux
alone. The difference between groups was not significant.
DISCUSSION
The cause of venous hypertension is multifactorial, with
components of venous outflow obstruction, venous incom-
petence, and calf muscle pump dysfunction. The risk of
CVI is increased in patients who have a history of DVT
compared with those who do not.3 Overall, 20% to 30% of
patients can be expected to progress to skin changes and 2%
to 3% to ulceration.1,26
In the present study, the subjects were all treated using
the same LMWH (dalteparin, Fragmin) and warfarin pro-
Table III. Clinical changes at 12 and 60 months post-DV
Proximal DVT*
CO Cl-3
N (%) N (%)
12 months 0 (0) 22 (85)
60 months 4 (15) 8 (31)
DVT, Deep vein thrombosis; CEAP, clinical, etiologic, anatomic, pathophy
*Includes combined proximal and proximal plus distal DVT
Table IV. Pattern of reflux in DVT and non-DVT limbs a
Deep veins
n (%)
Deep
v
DVT limbs (54)
Proximal DVT (26) 10 (38)
Distal DVT (28) 6 (21)
Non-DVT limbs (48) 5 (10)
DVT, deep vein thrombosis.tocol, and at 5 years they were evaluated by the samephysician (AR) and assessed by duplex ultrasound scanning
by the same vascular technologist (AA). This was therefore
a very uniform group of subjects in which to evaluate the
development of the post-thrombotic syndrome. The major
cause of DVT in our study was underlying thrombophilic
disorders (30 patients, 59%) associated with immobiliza-
tion (not necessarily postoperative).
Previous clinical trials comparing LMWH and unfrac-
tionated heparin in the treatment of DVT27-33 and a recent
study by Breddin et al34 indicate that LMWH is at least as
safe and more effective than unfractionated heparin in
reducing the size of the thrombus and more effective for
the prevention of the thromboembolism. Rapid recanaliza-
tion after DVT is related to a high incidence of valve
competency and minimizing the post-thrombotic syn-
drome morbidity.9
The effect of the location of thrombi on lysis rates is
controversial, with some reporting a lower resolution rate
with proximal versus distal thrombus4,8 and others demon-
strating no difference.35 In our study, all 28 limbs with
distal DVT showed complete resolution by 6months; in 19
of these the resolution had occurred within 1 week of
starting treatment. In the 26 limbs with evidence of prox-
imal DVT, 7 had resolved by 1 week, 21 by 6 months, and
all but 1 by 5 years. Although not all DVTs were occlusive,
these results are consistent with a slower rate of resolution
in proximal compared with distal DVT. This is likely to
relate to thrombus load.
The development of persistent symptoms and signs of
CVI is more likely to occur after proximal DVT than with
distal DVT. As shown in the present study, evidence of CVI
was obtained in 22 of the 26 proximal DVT limbs at 5
years, with skin changes (CEAP classes 4 to 6) in 14 (54%).
In contrast, only 3 (11%) of the distal DVT limbs showed
CEAP classification
Distal DVT
6 CO Cl-3 C4-6
) N (%) N (%) N (%)
5) 8 (29) 20 (71) 0 (0)
4) 13 (46) 12 (43) 3 (11)
ic.
60 months of follow-up
x present
Reflux absent
n (%)
perficial
(%)
Superficial veins
n (%)
6) 3 (12) 1 (4)
) 2 (7) 18 (64)
) 16 (33) 23 (47)T by
C4-
N (%
4 (1
14 (5
siologfter
Reflu
& su
eins n
12 (4
2 (7
4 (8skin changes at 5 years. Of the 17 limbs with DVT (14
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most common pattern of reflux was the combination of
deep plus superficial plus perforator venous incompetence
seen in 12 of the 17 limbs. Previous studies have identified
the importance of deep venous reflux as a key factor in the
development of more severe grades of CVI.17-22
An important long-term outcome of DVT is the devel-
opment of venous reflux in venous segments not previously
affected by the DVT itself.13 It has previously been re-
ported that after a DVT, reflux developed in up to one third
of venous segments not affected at the time of the initial
DVT.13 In the present study, proximal deep venous reflux
was demonstrated in 6 of 28 limbs in subjects who had 5
years previously had only a distal DVT, without proximal
extension, whilst under close surveillance. In addition, the
possibility of more systemic venous functional derange-
ment as a consequence of a DVT is raised by the findings of
deep venous reflux in 9 limbs, as well as superficial venous
reflux in 20 of the 48 limbs that had not been known to be
affected by venous thrombosis.
Although this is an unexpectedly high level of venous
incompetence in apparently unaffected limbs, it is impor-
tant to note that these limbs were not evaluated by ultra-
sound scanning at the time of the initial presentation. A
more definitive long-term tracking study of remote veins is
required to further explore the potential systemic effects of
a venous thrombosis.
CONCLUSIONS
The resolution of thrombus was more rapid and com-
plete in study subjects with distal DVT compared with
subjects with proximal DVT. Patients with proximal DVT
developed a more severe form of post-thrombotic syn-
Fig 2. Mean  SD of error of clinical CEAP score vers
thrombosis (DVT) at 5 years in follow-up.drome, likely to be related to the development of deepvenous reflux and incompetent perforators Although non-
DVT limbs were not examined at the initial presentation, a
potentially important finding of this study was the unex-
pectedly high incidence of venous reflux in these apparently
unaffected limbs, suggesting that DVTmay result in a more
systemic disorder of venous function.
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